Posts by Kelly Butler
Scientific Update: FGFR2 Pathway Activation as a Therapeutic Biomarker for FGFR2 Inhibitors
Fibroblast growth factor receptor 2 (FGFR2) is among cholangiocarcinoma’s most frequently altered genes.
Read MoreScientific Update: Phase II Study of a Novel Immunotherapy Combination for Cholangiocarcinoma
The first line of treatment for unresectable cholangiocarcinoma is gemcitabine plus cisplatin…
Read MoreScientific Update: Bile MicroRNA Profiling May Facilitate Cholangiocarcinoma Diagnosis
In diagnosing cholangiocarcinoma, it is essential to distinguish it from other conditions that can have similar symptoms or presentation…
Read MoreScientific Update: Modulating Alternative Splicing to Unleash Anti-tumor Immunity – A Novel Therapeutic Approach
A recent study explored the therapeutic regulation of PD-1’s alternative splicing for potential anti-tumor effects in cancer therapy research.
Read MoreScientific Update: Tiliacorinine may Slow Cholangiocarcinoma Growth – Mechanistic Insights into a New Potential Therapy
Tiliacora triandra is a plant native to Southeast Asia used for cooking and traditional herbal medicine.
Read MoreScientific Update – Bile Acids in Cholangiocarcinoma: A Potential Diagnostic Biomarker
In addition to aiding in digestion, bile acids may contribute to the formation and progression of gastrointestinal cancers.
Read MoreScientific Update – Radiation-releasing “seeds” may slow cholangiocarcinoma growth by inhibiting VEGFR2 singling
External radiation has been used to treat cancer for many years, but recent technological advances have led to a new form of radiation from implanted iodine 125 (125I) “seeds.” This new approach is advantageous since it allows high doses of targeted radiation with minimal damage to surrounding tissues while being more convenient for patients than…
Read MoreScientific Update – Circular RNA (circZNF215) in cholangiocarcinoma: A new possible therapeutic target
About 98% of the human genome is non-coding, meaning it does not contain the genetic code to make proteins. However, these non-coding regions are not “junk DNA.” Instead, they contain important regulatory elements that can affect gene expression, protein levels, and protein activity. One type of non-coding element is circular RNAs, and a recent study…
Read MoreMonthly Scientific Update – April 2023
Radiomics Models May Help Identify Candidates for Surgery Most cholangiocarcinoma tumors are unfortunately detected at advanced stages, but surgical resection is sometimes possible for earlier-stage cancers. To better identify patients who may benefit from surgery, researchers are working to develop ways to predict postoperative disease recurrence. A recent study thus identified variables associated with post-surgical…
Read MoreMonthly Scientific Update – February 2023
LCK Inhibitor: A Novel Potential Therapy for Cholangiocarcinoma A variety of signaling pathways can become overactive in cancer to promote cell growth. One of these pathways is known as the Hippo signaling pathway, which involves the activation of “yes-associated protein” (YAP). YAP is regulated by another protein called LCK, which can turn on YAP through…
Read MoreMonthly Scientific Update – January 2023
Apigenin-Conjugated Gold Nanoparticles: A Potential New Treatment for Cholangiocarcinoma
Read More